Lead sponsor
Weill Medical College of Cornell University
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
1
Active
4,918
Total enrollment
4
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Not applicable
1
Trials by status
Not yet recruiting
1
Completed
1
Withdrawn
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Comparative Effectiveness of Metformin for Type 2 Diabetes With Chronic Kidney DiseaseHbA1c ≥6.5%not applicableCompleted4,888